This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07217/identifier/chemspider/
n10http://bio2rdf.org/drugbank:
n5http://linked.opendata.cz/resource/drugbank/drug/DB07217/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB07217/identifier/pubchem-compound/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n7http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/drug/DB07217/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07217/identifier/drugbank/
n8http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07217
rdf:type
n7:Drug
n7:group
experimental
owl:sameAs
n10:DB07217 n14:DB07217
dcterms:title
N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide
adms:identifier
n4:99443688 n5:738 n6:766948 n12:670663 n13:DB07217
n7:IUPAC-Name
n8:271B5574-363D-11E5-9242-09173F13E4C5
n7:InChI
n8:271B557A-363D-11E5-9242-09173F13E4C5
n7:Molecular-Formula
n8:271B5579-363D-11E5-9242-09173F13E4C5
n7:Molecular-Weight
n8:271B5576-363D-11E5-9242-09173F13E4C5
n7:Monoisotopic-Weight
n8:271B5577-363D-11E5-9242-09173F13E4C5
n7:SMILES
n8:271B5578-363D-11E5-9242-09173F13E4C5
n7:Water-Solubility
n8:271B5572-363D-11E5-9242-09173F13E4C5
n7:logP
n8:271B5570-363D-11E5-9242-09173F13E4C5 n8:271B5573-363D-11E5-9242-09173F13E4C5
n7:logS
n8:271B5571-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Acceptor-Count
n8:271B5580-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Donor-Count
n8:271B5581-363D-11E5-9242-09173F13E4C5
n7:InChIKey
n8:271B557B-363D-11E5-9242-09173F13E4C5
n7:Polar-Surface-Area--PSA-
n8:271B557C-363D-11E5-9242-09173F13E4C5
n7:Polarizability
n8:271B557E-363D-11E5-9242-09173F13E4C5
n7:Refractivity
n8:271B557D-363D-11E5-9242-09173F13E4C5
n7:Rotatable-Bond-Count
n8:271B557F-363D-11E5-9242-09173F13E4C5
n7:Bioavailability
n8:271B5586-363D-11E5-9242-09173F13E4C5
n7:Ghose-Filter
n8:271B5588-363D-11E5-9242-09173F13E4C5
n7:MDDR-Like-Rule
n8:271B5589-363D-11E5-9242-09173F13E4C5
n7:Number-of-Rings
n8:271B5585-363D-11E5-9242-09173F13E4C5
n7:Physiological-Charge
n8:271B5584-363D-11E5-9242-09173F13E4C5
n7:Rule-of-Five
n8:271B5587-363D-11E5-9242-09173F13E4C5
n7:Traditional-IUPAC-Name
n8:271B5575-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-acidic-
n8:271B5582-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-basic-
n8:271B5583-363D-11E5-9242-09173F13E4C5